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                                  INTRODUCTION
Diabetes may be defined as a disturbance of intermediary metabolism 
manifesting as chronic sustained hyperglycaemia primarily due to either an absolute 
or relative lack of insulin. This may be accompanied by other biochemical disorders.
The metabolic deregulation associated with DM causes secondary 
pathophysiologic changes in the multiple organ systems that impose tremendous 
burden on the health care system. With increasing incidence worldwide, DM is 
likely to continue as a leading cause of morbidity and mortality for the foreseeable 
future.
Two broad categories of DM are designated as Type I and Type II. Type I 
DM results from auto immune β-cell destruction which leads to insulin deficiency. 
Type II DM is a heterogeneous group of disorder usually characterised by variable 
degrees of insulin resistance, impaired insulin secretion and increased glucose 
production.
CRITERIA FOR THE DIAGNOSIS OF DIABETES MELLITUS
• Symptoms of diabetes (Polyurea, polydipsia, weight loss) plus random blood glucose 
concentration ≥ 200 mg/dl.
or
• Fasting blood glucose ≥ 126 mg/dl.
or
• Two hour plasma glucose ≥ 200 mg/dl during an oral glucose tolerance test.
5In the absence of unequivocal hyperglycaemia and acute metabolic 
decompensation these criteria should be confirmed by repeat testing on a different 
day. 
Diastolic abnormalities have been observed in patients with DM. Impaired 
augmentation of LVEF during exercise occurs in upto 40% of patients. (5) Diastolic 
dysfunction and abnormal systolic reserve during exercise result from DM. (6) The 
association of DM to coronary artery disease and hypertension is well known.
So, early recognition of heart disease in diabetes is a desirable goal. Diastolic 
dysfunction, one of the earliest manifestations can be easily assessed by tissue 
doppler imaging.
6                            AIM OF STUDY
Diastolic dysfunction is considered the earliest manifestation of diabetes 
mellitus. The existence of diabetic candiomyopathy independent atherosclerotic and 
hypertensive heart disease has been established in adult population.(7)
There is also some controversy over the existence of diabetic 
cardiomyopathy. So keeping these things in mind, the aim of study is to determine 
whether diastolic dysfunction exists in an asymptomatic diabetic or not.
Both conventional echocardiography and Tissue Doppler Imaging (TDI) 
were used to evaluate diastolic function. There are several studies which show that 
TDI can diagnose diastolic dysfunction earlier than conventional echo-doppler. So, 
the most important part of the study is to compare both studies. (Conventional Echo 
& TDI)
Early diagnosis of diastolic dysfunction is a desirable goal. Early diagnosis 
leads to early intervention which saves the individual from the long term effects of 
DM. TDI method that help in the early diagnosis of diastolic dysfunction in diabetes 
is a welcome addition to the diagnostic armamentarium.
7                       REVIEW OF LITERATURE
The role left ventricular (LV) diastolic dysfunction in health and disease is 
not yet understood fully. This is because diastole is a complex phenomenon consists 
of several phases that encompass the relaxation and then filling of ventricles (8,9). 
Physical examination, ECG, and chest radiographs are unreliable in making the 
diagnosis of LV diastolic dysfunction in most individuals, and invasive 
measurements of cardiac pressures, rates of LV relaxation, and LV compliance are 
costly, clinically impracticable as they carry increased risk and require special 
catheters and software analysis programmes (10). 
One of the first attempts to explain ventricular filling was provided by Galen 
in 100 BC who proposed that the heart is filled by dilatation of the right ventricle. In 
1628, William Harvely recognised the heart was a central pump in circulatory 
system containing arteries and veins. Diastole was largely ignored as simply the 
interval in which the cardiac chambers passively filled in between each pumping 
cycle.
Gradually clues emerged that LV diastolic dysfunction alone can cause 
symptoms and that diastolic and systolic functions were interrelated. An important 
discovery was the Frank-Starling mechanism whereby LV end diastolic volume help 
regulate LV stroke volume on a beat to beat basis. Another landmark observation 
was made by KATZ, who observed that after mitral valve opening in mammalian 
hearts LV pressure continues to decrease while volume is increasing, thereby 
demonstrating that the heart acts as suction pump.
With the advent of cardiac catheterisation in the 1960s, the study of 
cardiovascular biomechanics accelerated. Although most research continued to 
8focus on LV systolic function, cardiac diseases with thickened and non complaint 
ventricles were reported. Soon, angiographic differences in LV filling patterns 
between normal and patients with various heart diseases were noted (11).
In mid-1980s, echocardiographic studies helped show that 20 to 40% of 
patients with symptoms of CHF had normal LV ejection fraction and possibly 
diastolic dysfunction as the etiology. Because of the difficulties in quantitating 
individual LV diastolic properties, the clinical study of LV diastolic dysfunction 
proceeded slowly. In1982, the use of PW Doppler mitral flow velocities to study LV 
filling was described. Easy to use, noninvasive nature and ability to study changes in 
LV filling after interventions made this technique to revolutionise the study of LV 
diastolic dysfunction. Tissue Doppler imaging is a recently developed ultrasound 
technique that has underlying physics and principles similar to those of conventional 
PW spectral Doppler.
Heart disease was thought to be associated with diabetes as early as 1882, 
when Vergerely recommended testing the urine of patients with angina for glucose. 
The association of diabetes to coronary artery disease and heart failure is well 
known. The question whether diabetes itself, distinct from CAD and hypertension, 
results in dilated candiomyopathy remains controversial.
In the 35 to 64 year old Framingham Cohort, diabetes increased the risk 
congestive heart failure in men four fold, and in women eightfold, even after 
adjustment for blood pressure, age, cholesterol, weight and a history of CAD (12). 
The more recent Washington DC dilated cariomyopathy study used case control 
analysis to determine that there was an association between diabetes and idiopathic 
cardiomyopathy (13). Furthermore various groups have reported diastolic 
abnormalities using various parameters including prolonged IVRT and abnormal 
9transmitral flow velocities. Increased ehodensity has also been reported despite 
normal wall thickness(14).
Recently SARAIVA ET AL, have studied diastolic dysfunction in diabetic 
patients by conventional echo and tissue Doppler imaging (TDI) methods (15).
Similar studies has also been done by many authors.
Boyer ET AL studied the prevalence of ventricular diastolic dysfunction in 
asymptomatic normotensive patients with diabetes melliton (16).
Vinereanu ET AL studied the subclinical left ventricular dysfunction in 
asymptomatic patients with type II DM related to serum lipids and glycated 
haemoglobin (17). 
Poirier ET AL studied Diastolic dysfunction in normotensive men with well 
controlled Type II diabetes (19).
The guidelines for the diagnosis of diastolic dysfunction was issued by 
European Study Group on Diabetic Heart Failure (18).
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 OVERVIEW OF DIABETES MELLITUS, 
DIASTOLOGY AND DIASTOLIC DYSFUNCTION
DIABETES MELLITUS 
Diabetes is the seventh leading cause of death in the west, with much of that 
mortality a result of cardiovascular disease. A two to four-fold excess in mortality 
due to coronary artery disease (CAD) among individuals with diabetes has been 
noted in a number of prospective studies. Diabetes also increased the risk of severe 
carotid atherosclerosis and mortality from stroke increased almost three fold in 
patients with diabetes. Both type I and type II diabetes are therefore powerful and 
independent risk factors for CAD, stroke and peripheral arterial disease. 
The prevalence of type II diabetes which accounts for 90% of all cases of 
diabetes is increasing world over. This is due to advancing age of population, 
improved screening and detection and increase in risk factors such as obesity and 
physical inactivity.
Life expectancy is shortened, with diabetic males living on an average 9.1 
years less and diabetic females living 6.7 years less than their non diabetic counter 
parts (20).
Haffner and colleagues examined the mortality among 1000 persons with 
Type II DM and 1300 subjects without diabetes and found that mortality of those 
with diabetes was similar to that for those without diabetes who had a myocardial 
infarction (MI) (21). This data suggest that caregivers should treat individuals with 
type II diabetes as if they have experienced an MI. Malmberg et al evaluated the 
findings of OASIS (organisation to assess strategies for ischaemic syndromes) 
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registry and found that patients with diabetes hospitalised for unstable angina or non 
- Q MI had the same long term morbidity and mortality as patients without diabetes 
with established cardiovascular disease (22).
Many of these patients with type II diabetes have several of these risk factors 
for CAD. The term METABOLIC SYNDROME was first used by Gerald Reaven in 
1988 to describe the clustering of risk factors including hypertension, dyslipidaemia, 
hyperglycaemia and insulin resistance. The National Cholesterol Education Program 
Adult Treatment Panel III (ATP III) guidelines for cholesterol management in 2001 
recognised that the metabolic syndrome is a collection of risk factors mentioned 
above as well as abdominal obesity.
The increased risk of cardio vascular disease in diabetics is partly expalined 
by clustering of risk factors, including dyslipidaemia, hypertension, hyper 
glycaemia, hyper insulinaemia and prothrombotic factors.
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Chronic Complications in DM
Non Vascular Complications
Gastroparesis, sexual dysfunction and skin changes.
The risk of chronic complications increases as a function of the duration of 
DM.
Since Type II DM may have a long asymptomatic period of hyperglycaemia, 
many individuals with type II DM have complications at the time of diagnosis.
Congestive Heart Failure
Individuals with DM have increased incidence of congestive cardiac failure. 
The etiology of this abnormality is probably multifactorial and include factors like 
myocardial ischaemia from atherosclerosis, hypertension and myocardial cell 
dysfunction secondary to chronic hyper glycaemia.
Diabetic Cardiomyopathy
Vascular complications
Microvascular
Coronary artery disease
Peripheral Vascular Disease
Cerebrovascular Disease
Macrovascular Complications
Retinopathy
Neuropathy
Nephropathy
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Diabetic Cardiomyopathy is defined as heart failure in the absence of 
identifiable etiology. In the Framingham heart study few patients with heart failure 
did not have CAD/hypertension or RHD. The term diabetic cardiomyopathy was 
first coined by Rubler in 1972.
MECHANISMS LEADING TO HEART FAILURE IN DM
DIABETES
Clinical Heart Failure
Diastolic dysfunction and abnormal systolic reserve during exercise may 
result from Diabetes. 
The diagnosis of diabetic cardiomyopathy is sometimes invoked when a 
patient with diabetes has evidence of heart failure in the absence of identifiable 
etiology. One of the difficulties in making this diagnosis is lack of definite 
pathological findings so that differentiation from DCMP remains problematic. The 
diagnosis of diabetic cardiomyopathy was suggested almost 30 years back. 
Parelleling the incidence of CAD in patients with diabetes is the incidence of heart 
Abnormal Systolic ReserveDiastolic dysfunction
HypertensionCoronary artery disease
Renal InsufficiencyObesity
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failure. Heart failure is a frequent clinical manifestation of the end stage of 
cardiovascular complications that affects the patients with DM. Framingham heart 
study was the first study that showed the risk of symptomatic heart failure with 
increased 2.4 - fold incidence in men with diabetes and five fold in women with 
diabetes. Hypertension occurs in is 40% to 60% of patients with type II DM. 
Hypertension is the most common cause of heart failure in patients with DM after 
CAD, amounting to 25% of the cases.
Pathologically post mortem studies of patients with diabetic cardiomyopathy 
have revealed that they have features similar to those of patients with other forms of 
non ischaemic cardiomyopathy. This include myocyte hypertrophy, interstitial 
fibrosis and infiltration with periodic Acid schiff stain positive materials with 
coronary arterioles having thickened basement membrane as well as the presence of 
intramyocardial microangiopathy. Theories abound regarding mechanism or 
mechanisms underlying diabetic cardiomyopathy. These include both cellular and 
molecular perturbations, as well as metabolic abnormalities.
Calcium homeostasis may be altered and has been reported in various animal 
models of DM, suggesting a diminished but prolonged increase in the intracellular 
calcium concentration.
Hyperglycaemia increases calcium activated signalling through protein 
kinase C which in turn may result in cardiac dysfunction. Abnormalities in 
myofibrillar proteins including altered posphorylation of troponin I and myosin light 
chains may also play a role in diabetes associated impairment of contractile function 
(23). Advanced glycosylation result in abnormal collagen cross-linking, which may 
contribute to decreased compliance and in turn to diastolic dysfunction. 
In the United Kingdom Prospective Diabetes Study (UKPDS) the incidence 
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of heart failure correlated with the extent of hyperglycaemia. Myocardiac fibrosis 
underlies the pathologic hypertrophy and dysfunction that are observed in Heart 
failure.
Pathogenesis of Heart failure in DM
Increasing blood glucose concentration is an independent and continuous risk 
factor for the cardiovascular disease. The progressive relationship between glucose 
levels and cardiovascular risk begins at less than the glucose threshold that is 
required for the clinical diagnosis of diabetes. The risk of heart failure increases by 
15% per 1% increase in HB-AIc in individuals who do and do not have known 
diabetes. Hyperglycaemia alters protein knase C, (PKC) increases oxidative stress 
and up regulate the activity of Angiotensin converting Enzyme (ACE) and other 
compounds of RAAS, which contributes to the development of cardiomyopathy.
Molecular Mechanisms
PKC has been linked closely to the mechanism that underlies 
hyperglycaemia induced biochemical alterations, persistent PKC activation results 
from chronic hyperglycaemia may lead to alterations in cell growth and function by 
way of PKC dependent posphorylation of myocardial and skeletal muscle enzymes 
and proteins that may affect muscle contractility, gene expression and growth. PKC 
may interefere  with contractile proteins troponin T, Tropnin - I troponin - 
Tropomysin complex and troponin-C proteins as well as inhibition of Ca++ 
activated myofibrillar actomyosin Mg++ AT pase activity and contractility.
ACE in particular may account for development of abnormalities that 
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contribute to the development of diabetic cardiomyopathy. The increase in ACE 
activity in diabetics may be direct consequence of glucose mediated activation of 
PKC.
The presence of DM alters the way the myocardium uses lipids in general 
and FFA in particular. The normal heart uses fatty acids for approximately 70% of 
its energy sources. In diabetic heart there is a greater reliance on fatty acid oxidation. 
There is a depression of glucose oxidation in the heart during diabetes that probably 
is due to the inhibition of pyruvate dehydrogenase kinase.
Insulin Resistance
Insulin resistance is commonly present in heart failure even in the absence of 
diabetes and independent of the cause of heart failure. The failing heart metabolises 
carbohydrates and FFAs for energy production and insulin resistance compromises 
this mechanism.
Diabetics have higher systolic blood pressures, higher pulse pressures and 
longer duration of hypertension than non diabetics. Compared to non-diabetic 
hypertensives diabetics has decreased stress corrected mid wall shortening.
Diastolic dysfunction in Diabetes
Diastolic abnormalities have been observed in patients with DM, Impaired 
augmentation of LVEF during exercise occurs in upto 40% of patients Echo studies 
have demonstrated prolonged IVRT, delayed opening of mitral valve, decreased rate 
of LV diastolic filling and abnormal transmitral flow velocities. Diastolic 
abnormalities may be present earlier than and independent from systolic 
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abnormalities in patients with DM.
Diastolic dysfunction implies elevation of left ventricular end diastolic 
pressure with normal LV end diastolic volume and normal ejection fraction.
The pathophysiology relating to diastolic heart failure is related  to an 
increase in ventricular filling pressure relative to volume and secondary to either 
myocardial or pericardial disorders.
Restrictive cardiomyopathy is a broad category of myocardial diseases 
characterised by decreased passive chamber compliance, usually without significant 
systolic dysfunction. It can result from various systemic and local disorders. 
The addition of Doppler imaging to conventional Doppler Echocardiography 
demonstrated diastolic dysfunction in 75% of 57 asymptomatic normotensive 
diabetic patients. TDI detected diastolic dysfunction more often than any other 
echocardiographic approach.
Diastology
We define diastole as starting with the onset of isovolumic relaxation and 
ending with the closure of mitral valve. Diastole thus includes isovolumic relaxation 
period and diastolic filling period. Until recently diastole was considered as a 
passive portion of cardiac cycle. Within the last few decades there has been a 
growing realisation that heart failure can occur in the presence of normal systolic 
function (24).
Using Echocardiography, it is now possible to noninvasively measure 
chamber dimensions, motion of the mitral annulus, motion of the chamber walls, 
transmitral and pul. Vein flows and intra cardiac flow (25).
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Phases of diastole
a) Isovolumic Relaxation Phase
In this phase there is no LV filling, but it has an impact on filling of LV in 
the subsequent phase. This is an active phase and requires lot of energy.
b) Rapid Filling Phase 
Major portion of the ventricular filling occurs during this phase and is 
governed by myocardial relaxation, mitral valve gradient and myocardial 
compliance.
c) Slow Filling Phase
This is dependent on the passive compliance or stiffness of ventricle. Very 
little filling occurs during this phase.
d) Atrial systole
The contribution of atrial contraction towards ventricular filling depends on 
the LV compliance and rhythm of the patient. Normally the atrial contraction 
contributes upto 15% of LV filling. But if the LV is less compliant the contribution 
may increase to 30-35%.
Although there are numerous independent factors that affect LV diastolic 
properties and the filling of LV, all factors work through their combined resultant 
effects on the transmitral gradient (TMPG) which is the actual physical determinant 
of LV filling. The effects of two key diastolic properties, the rate of LV relaxation 
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and LV compliance are especially important in the understanding of LV filling 
patterns in health and disease.
LV relaxation describes the rate of LV pressure decline during isovolumic 
relaxation. Quantitation of LV relaxation is done by describing the rate of LV 
pressure decline during isovolumic relaxation (26). Another key LV diastolic 
property is the operating chamber compliance (dV/dp). This affects the LA and LV 
filling pressures and is composed of stiffness. The LV chamber stiffness is described 
by a tangent, the steeper the slope of the tangent the less complaint (Stiffness) is the 
ventricle.
The TMPG determines the LV filling pattern and is influenced by the speed 
of LV relaxation and LV compliance. For any given LV pressure, faster LV 
relaxation results in a larger early TMPG, more filling in early diastole and 
consequently less filling in late diastole. Conversely, when LV relaxation is slowed, 
the proportion of early diastolic filling declines and a greater proportion is seen at 
atrial contraction. Because the rate of LV relaxation and LA pressure is a continuum 
many different TMPGs and LV filling patterns are possible. Impaired or slowed LV 
relaxation is the earliest and commonest diastolic abnormality, with a decrease in 
LV compliance and increase in filling pressures seen in patients with more advanced 
and symptomatic cardiac disease.
Mitral floor velocity variables
Left ventricular isovolumic relaxation time (IVRT) is the time interval from 
Aortic Valve closure to mitral valve opening. Longer IVRT values (>100 ms) are 
associated with impaired relaxation and normal filling pressures. This lengthening of 
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IVRT interval is the earliest change seen with diastolic dysfunction and is sensitive 
to slowing of the rate of LV relaxation. A short LV IVRT indicates an earlier mitral 
valve opening and can be seen in young normal individuals or patients with 
increased mean LA pressure. (Fig-2)
Peak E-wave velocity reflects early diastolic TMPG. Similarly peak mitral A 
wave velocity reflects the late diastolic TMPG. The overall type of filling pattern is 
generally characterised by the mitral E to A wave ratio.
Normal Values for mitral flow velocity curves
E-Velocity 0.85 ± 0.16 m/sec
A-Velocity 0.56 ± 0.13 m/sec
DT 160 - 240 msec
1VRT 70 - 100 msec
Normal E/A ratio - 1.6.
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Fig-1
Different components of mitral valve inflow
Fig-2
Schematic representation of mitral inflow (top) mitral annular Doppler 
tissue imaging
(middle) and pulmonary vein flow (Bottom) in a normal individual in 
various grades of diastolic dys function
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Elastic recoil and rapid LV-relaxation in adolescents and young adults results 
in a predominance of early diastolic filling (E-wave) with much less filling 
(10-15%) caused by atrial contraction. With normal aging LV systolic function 
changes little but LV relaxation slows in most individuals. This appears to be caused 
by an increase in systolic BP and LV mass. The result is reduced LV filling in early 
diastole and increased filling at atrial contraction. In most individuals the peak 
E-wave and A wave velocities become approximately equal during the 7th decade of 
life.
Abnormal patterns of diastolic dysfunction
In patients with cardiac disease three abnormal LV filling patterns are 
recognised. (Fig-2)
The least abnormal and most common is termed impaired relaxation 
resulting from reduced filing in early diastole, a reduced Mitral E to A velocity ratio, 
increased A wave amplitude and filling caused by atrial contraction and often on S4 
gallop.
Diastolic dysfunction
1. Abnormal Relaxation pattern
2. Pseudonormalisation
3. Restrictive pattern
a. Reversible
b. Irreversible
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With disease progression the LV compliance become reduced and LA pressure 
increases which counteracts the impaired LV relaxation. The increased early TMPG 
results in an LV filling pattern that appears normal but is actually pseudo-normal. 
This term indicates that despite the normal mitral E to A wave ratio abnormalities of 
LV relaxation and LV compliance are present. Finally in patients with advanced 
disease and 
Table 3 : Abnormal Relaxation Pattern
E-Velocity < A Velocity
DT > 240 m/sec
IVRT > 100 m/sec
E/A Ratio < 1
Table 4 : Pseudo normalisation
DT 160-200 m/sec
IVRT < 90 m/sec
E/A 1 - 1.5
PVs2 < Pvd
Mitral A duration < Pva duration
Pva > 35 cm/sec.
a severe decline in LV compliance, the high pressures cause the LV filling to 
become restrictive with blood rapidly entering a slowly relaxing ventricle in early 
diastole only to be abruptly decelerated generating an S3 gallop. With a marked 
increase in early LV diastolic pressure the Lt atrium is dilated and hypercontractile 
with little additional filling at atrial contraction. When restrictive pattern is
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Table  : Restrictive Pattern
E Velocity < A velocity
DT < 150 m/sec
IVRT < 70 m/sec
E/A Ratio 2
observed, increasing E velocity indicates increasing LA pressure and decreasing A 
wave correlates with increasing LVED pressure.
In early phases this pattern may be reversible by changing the loading 
conditions of the heart by drugs like nitrites. When it becomes irreversible it 
indicates end stage of the disease. The patient has dyspnoea at rest or minimal 
exertion, S3 is present and prognosis is poor.
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ECHO-DOPPLER EVALUATION OF LEFT 
VENTRICULAR DIASTOLIC FUNCTION
Although a variety of modalities are available to evaluate diastolic 
dysfunction, Echo-Doppler study has emerged as the modality of choice because of 
the rapidity with which it gives information, its being non invasive and its 
repetitiveness.
Modalities used to evaluate diastolic function
1. Echo-Doppler
2. Radionuclide Studies
3. Haemodynamic Studies
4. Tissue Doppler Studies
Echo Doppler
The functional behaviour of the normal and pathologic cardiac chamber can 
now be assessed non-invasively. Virtually all types of acquired heart diseases are 
associated with a component of diastolic dysfunction. The diastole comprises 2/3 of 
cardiac cycle. Lt ventricle diastolic pressure is transmitted to the Lt atrium and to the 
pulmonary veins for a relatively longer period than in systolic pressure. 
Transmission of elevated diastolic pressures to the pulmonary reins can be a 
substantial driving force in development of pulmonary hypertension. Because 
diastole comprises two thirds of cardiac cycle, diseases that elevate diastolic 
pressure are more likely to be associated with secondary pulmonary hypertension 
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than are diseases with isolated systolic pressure. Diastolic dysfunction is a 
significant contribution to the development of congestive heart failure. Although 
there are a number of medical and surgical treatments available for systolic overload 
of LV like Aortic stenosis, there are fewer options for the treatment of diastolic 
dysfunction.
There are numerous techniques for evaluation of diastolic dysfunction.
Table-I
Anatomy Level - Continuous diastolic volume 
Diastolic filling rate
Flow based - Mitral 
valve inflow pattern
E/A Ratio
Deceleration Time
Isovlumic Relaxation Time
Dimension less Myocardial Performance Index (MPI)
Pulmonary Vein Flow
Doppler Tissue Imaging
Mitral annular diastolic velocity
Mitral valve E-wave / EA ratio.
M-mode Echo Cardiography
It plays little role in the evaluation of diastolic function. One M-mode 
finding that has retained clinical relevance is the presence of B hump of mitral valve 
closure. It is an indication of elevated diastolic pressure, but it provides no quantity 
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information.
Two Dimension Echo Cardiography
It is an excellent tool that can identify, characterise and quantify diseases that 
caused by diastolic dysfunction. The combination of thickened left ventricular walls, 
Lt atrial dilatation and absence of mitral valve disease is a strong indication for the 
diastolic dysfunction.
Evaluation of Mitral inflow
Mitral inflow pattern in evaluated from an apical transducer position with 
sample volume placed at the tip of the mitral valve. Normal mitral inflow consists of 
a biphasic flow with mitral E-wave exceeds the A wave both in velocity and 
volume. An additional commonly used measurements is deceleration time of E-
wave with delayed LV relaxation, there is prolongation of deceleration time.
Determination of IVRT
IVRT represents Isovolumic Relaxation time (IVRT). This is the earliest part 
of diastole - It is defined as the time from Aortic Valve closure and mitral valve 
opening and is 76 ± 13 m/sec in adults. Diseases that result in elevation of left atrial 
pressure will shorten the IVRT.
Myocaridal Performance Index (MPI)
This is derived by comparing the total systolic time from mitral valve closure 
to mitral valve opening with systolic time involved in actual aortic flow or ejection 
time. The total systolic time in defined as isovolumic contraction time (IVCT) + 
Ejection time + IVRT. The MPI is derived as follows.
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(IVCT + IVRT)
MPI = ––––––––––––––––––––––
ET
normal MPI is less than 0.40. It combines by systolic and diastolic function.
TISSUE DOPPLER IMAGING 
It is a recently developed ultrasound imaging modality that has underlying 
physics and principles similar to those of conventional PW spectral Doppler. Instead 
of blood flow, TDI measures the velocity of myocardium during cardiac cycle. 
Blood flow is typically low amplitude and high velocity in nature, whereas 
myocardial velocities are of higher amplitude and low velocity. The limitations of 
TDI are also similar to standard Doppler in that PW display, while having a high 
temporal resolution, only measures velocities at a single point within the heart. TDI 
cannot separate translational and rotational components that also occur with 
myocardial contraction and relaxation. To minimise this limitation, imaging from 
the longitudinal axis plane (apical window) is performed. From this view the axial 
motion of the left ventricle is parallel to the transducer axis and the velocities are 
primarily related to LV contraction and relaxation. For TDI spectral analysis a 3-7 
mm PW sample volume is placed in different segments of LV (such as septum, and 
lateral, anterior, inferior or posterior walls) and regional quantification of segmental 
velocities are obtained. The PW sample volume is placed within the septal or lateral 
regions of the mitral annulus. The TDI function of the ultrasound machine is 
activated. (Fig-4)
In Sinus Rhythm there are two annular motions (Ea and Aa) In normal disease 
free state Ea is greater than Aa similar to the relationship of mitral E and A waves. 
With diastolic dysfunction there is reduction in Ea and the annular Ea/Aa ratio 
reverses. The annular velocity is not volume dependent as opposed to mitral inflow.
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Fig-3
Calculation of myo cardial performance index (MPI)
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Fig-4
Technique for spectral tissue Doppler imaging of mitral annular motion
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There is a positive (toward apex) systolic signal (Sm) and negative signal in 
early (Ea) and late diastole (Aa)(27).
Similar to transmitral profiles patients with impaired ventricular relaxation 
owing to LV hypertrophy or aging often have an MAM. Ea/Aa ratio of less than 1.
(28).
Combined TDI mitral annular and conventional PW Doppler variables have 
been used to estimate LV filling pressures.
The ratio of early diastolic velocities obtained with standard PW Doppler (E-
Wave) to MAM Ea wave have been related to pulmonary wedge pressures. Various 
investigators have used E/Ea ratios of 10, 12 or 15 to stratify pulmonary capillary 
pressures exceeding thresholds of 18-20 mmHg. An elevated E/Ea ratio has been 
associated with poor prognosis in both ischaemia and non-ischaemic left ventricular 
dysfunction.
Colour Doppler M-mode imaging
For evaluation of diastolic function mitral inflow propagation velocity is 
evaluated from LV apex. This technique can document reduced flow velocities that 
are manifest as a reduced slope of colour Doppler-M-mode signal. In normal 
situation there is a rapid slope implying high velocity of flow. In diastolic 
dysfunction, the velocity of early filling is reduced and organized propagation of 
flow does not occur past the midventricle.
Left atrial Volume / Size
Several recent studies have shown the prognostic importance of measuring Lt 
atrial size. Lt atrial size is an indirect marker of LV diastolic dysfunction.
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PULMONARY VEIN FLOW
As with mitral flow velocity, Pul.Venous velocity changes with normal aging 
and disease states. With experience high quality PW Doppler transthoracic 
recordings can be obtained in approximately 85% to 90% of patients. The 
haemodynamic determinants of Pul. Venous flow velocity recently have been 
studied in vivo. This include peak flow velocity in early systole (PVS1) late systole 
(PVS2) and early diastole and peak reverse flow velocity at atrial contraction and its 
duration. (PVa dur)
PVS1 occurs as a result of LA relaxation and pressure decrease. PVS2, which 
peaks later in sysole reflects the interaction of RV stroke volume, LA pressure and 
compliance. Pul. Venous diastolic flow velocity (PVd) initially follows early 
diastolic mitral flow velocity, but in mid diastole LV filling slows, whereas PVd 
flow continues with ongoing LA enlargement.
Pulmonary venous flow reversal owing to atrial contraction (PVa) is 
determined by LA contractility and compliance of the pulmonary venous bed, LA & 
LV. Pulmonary venous flow velocity patterns can be matched to their corresponding 
mitral Doppler patterns. Pul. venous systolic to diastolic flow velocity ratios help 
determine the type of LV filling pattern. The relation between pulmonary Pul. 
Venous A wave and mitral A wave duration is of special importance (29). When 
accurately recorded, this relation is an important age-dependent indication of La 
wave pressure increase and LV and diastolic pressure.
Simply stated, when the LA contracts the net volume and duration of flow 
under normal conditions should be greater, flowing forward into LV rather than 
backward into Pul. Vein. If pulmonary venous A wave is increased either in velocity 
(>35 cm/sec) or duration > 30 msec longer than mitral A wave duration, LV A-wave 
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pressure is increased and end-diastolic pressure is elevated.
Typically, imaging is performed from the apical view. The Rt pulmonary 
vein is most easily visualized. The sample volume can be placed at the orifice of Pul 
vein and PW Doppler imaging is used to record the flow envelope. With increasing 
stiffness and decreasing compliance of LV, emptying of the Lt. atrium becomes 
incomplete during diastole. Because of this, at the onset of systole, the Lt atrial 
volume and pressure are elevated. This results in a reduction of flow volume into the 
left atrium from Pul veins during ventricular systole.
The pulmonary A wave duration can be compared with the mitral A wave 
duration. Evaluation of  Pul. Venous flow can give valuable clue to the presence of 
pseudonormalisation, when a normal mitral inflow E/A ratio has been noted in a 
situation in which diastolic dysfunction is likely. In this instance, the pul vein flow 
will reveal blunted systolic velocities and relatively greater diastolic inflow with 
accentuation of A wave.
Renee L. Bess et al conducted a study to determine which Doppler para-
meters could be most successfully obtained. They concluded that MV flow and TDI 
annular velocities can be recorded in virtually all patients, require the least time to 
record and demonstrate low inter-reader variability (30).
So in this study we have selected MV flow, TDI annular velocities and 
pulmonary venous flow studies to evaluate our patients. The success rate in MV 
flow and TDI was 100% and Pulmonary venous flow 85%.
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Table II
European study group of diastolic heart failure guidelines (18)
E/A < 50 yrs < 1 and DT > 220 m/sec.
E/A > 50 yrs < 0.5 and DT > 50 years > 280 m/sec.
S/D < 50 yrs > 1.5 S/D > 50 years > 2.5 m/sec.
1 VRT < 50 yrs > 92 m/sec IVRT 30-50 yrs > 100 m/sec.
I VRT > 50 yrs > 105 m/sec.
PVA velocity > 35 cm/sec.
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MATERIALS AND METHODS
Patients were selected consecutively from those attending as outpatients to 
the Diabetic clinic attached to Govt. Stanley Hospital, Chennai - 1. 89 patients were 
selected initially. A thourough clinical examination was made to rule out the 
presence of any diseases. BP was recorded for 3 days in all the patients and BP 
reading > 130/85 on any one occasion were excluded from the study. Patients with 
other medical illnesses were excluded. Height and weight were recorded in all the 
patients. Resting ECGs were taken for all patients. Patients with abnormal ECGs 
were excluded. Random blood sugar was estimated in all the patients. Fasting blood 
sugar was estimated the next day. By this process 39patients were excluded from the 
study.
Since CAD, hypertension, peripheral vascular diseases were commonly 
associated with diabetes these patients were screened for them. Urine analysis and 
renal function tests were done in all the patients. Ophthalmological opinion was 
obtained whenever necessary. TMT was done in all patients and those with positive 
TMT test were excluded.
The study period was from January 2007 to December 2007. 50 patients 
were selected. There were 34 males and 16 Females.
All the selected patients fulfilled the following criteria.
1. Type II Diabetes Mellitus
2. Duration of DM > 5 years
3. Under Regular Treatment
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4. Age below 55 years.
Exclusion Criteria
1. Blood pressure > 130/85.
2. Abnormal Resting Electro Cardiogram
3. Positive Tread Mill Test for inducible ischaemia.
4. Patients with micro vascular or macro vascular complications of diabetes.
5. Patients above 55 years of age.
The effect of age on the diastolic function is known. So the upper age of the 
study group is arbitrarily fixed at 55 years.
The diagnosis of diabetes was established according to the current WHO 
criteria. Tread mill tests were done by cardiologists who were blinded to 
Echocardiographic diagnosis. Both treadmill test and Echocardiography were done 
on the same day.
Body mass Index was calculated as weight in kilograms divided by squared 
height in meters.
Twenty healthy subjects drawn from attenders of patients served as control 
group.
Prior approval from institutional ethic committee was obtained and all 
subjects gave written informed consent. 
TREADMILL TESTING
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All subjects including controls did the same symptom limited graded 
exercise test on a treadmill. Bruce Treadmill protocol was applied to all patients. 
Time in seconds on the Tread mill was used to evaluate exercise capacity and 
number of metabolic equivalents (METs) was estimated. Blood pressure was 
recorded with a manual mercury sphygmomanometer. BP and Heart rate was 
recorded every 3 minutes. An average 12 lead electro cardiogram monitored cardiac 
status during the exercise test.
Echocardiography
All subjects including controls underwent Echo evaluation. They were 
examined in the left lateral decubitus position using standard views. Studies were 
done using an ALOKA SSD 4000 phased array system equipped with tissue Doppler 
and harmonic imaging technology. Parasternal long axis, parasternal short axis as 
well as apical 4 chamber, five chamber and two chamber views were used for the 
evaluation of functions of left ventricle and the heart valves. LV dimension and 
fractional shortening (FS) of left ventricle were calculated by using Teicholtz 
formula. Ejection fraction was obtained by modified Simpsons' method.
Pulsed wave Doppler measurements of mitral inflow were obtained with the 
transducer on the four chamber view with a 1-2 mm Doppler sample volume placed 
between the tips of the mitral leaflets during diastole. The left ventricular outflow 
velocity curve was recorded from the apical five chamber view with the sample 
volume positioned just below the aortic valve.
Doppler velocities and time intervals were measured from mitral inflow and 
left ventricular outflow recordings. Isovolumic relaxation time (IVRT) was the time 
interval from the cessastion of left ventricular outflow to the onset of mitral inflow. 
Ejection time was the time interval from the onset and cessation of left ventricular 
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outflow. Deceleration time (DT) was the time interval between the peak E velocity 
and the end of the early diastolic flow. Total systolic time interval was measured 
from the cessation of one mitral flow to the beginning of the following mitral 
inflow. Isovolumic contraction time (IVCT) was calculated by subtracting ET and 
IVRT from total systolic time interval.
Tissue Doppler echo was performed by activating the tissue Doppler 
function in the same machine. Images were obtained in the apical 4 chamber view 
with the filter setting were kept low and gains were adjusted at the minimal optimal 
level to minimize noise. 1.7 mm sample volumes were placed at both septal and 
lateral mitral annular site and systolic velocity (Sm) early and late diastolic velocities 
(Em or E1, Am or A1) were obtained and average values were taken. E/E1 ratio was 
calculated. TDI was less sensitive to preloading conditions (31).
Pulmonary venous flow recordings were obtained from apical 4 chamber 
view with the sample volume positioned 1-2 cm into the right upper pulmonary vein 
and following measurements taken.
• Peak S-wave inflow velocity (cm/sec) during ventricular systole.
• Peak D-wave inflow velocity (cm/sec) during early phase of ventricular 
diastole and corresponding S/D ratio.
• Peak reversed A-wave (PVA) velocity (cm/sec) during atrial contraction.
Although all echo Doppler indices remain imperfect and much remains to be 
learned the aggregate sum of this information remains our best and most practical 
way to assess diastolic function, and to objectively follow serial changes after 
medical intervention or with disease progression.(32)
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Combined TDI mitral annular and conventional PW Doppler variables have 
been used to estimate LV filling pressures. The ratio of early diastolic velocities 
obtained with standard PW Doppler(E-wave)to MAM Em waves have been related 
to pulmonary wedge pressures.(33)
Despite epidemiologic observations of greater frequency of heart failure in 
diabetic subjects and credible explanations for LV Dysfunction, some studies in 
diabetic patients without overt evidence of heart disease have demonstrated normal 
contraction at rest. In these circumstances the contractile response during exercise 
was abnormal suggesting loss of contractile reserve in early phase of diabetic heart 
disease. In this situation the resting changes may be too subtle to be identified with 
load dependent indicators like ejection fraction, and require the application of 
sensitive techniques(35). 
STATISTICAL ANALYSIS
Datas are expressed as mean value ± standard deviation (SD) statistical 
significance was defined as P < 0.05. Statistical analysis was done by using SPSS 
software system.
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RESULTS AND ANALYSIS
The total number of subjects were 50.The number male patients is 34 (68%) 
and female patients were 16 (32%). The age group ranges from46.7 ± 7 Average 
length of the duration of diabetes is 7.5 ± 0.8 years. All patients have normal LV 
systolic function.
Table III
Demographic characteristics of diabetic patients
Age - years 46.7 ± 7
Body mass Index 24.5 ± 0.65
Male Gender 68%
Female Gender 32%
Systolic Pressure mm Hg 118.5 ± 1.8
Diastolic pressure mm Hg 72.5 ± 1.5
Length of time since the 
diagnosis of DM 7.5 ± 0.8
Diastolic dysfunction was present in 18 patients (36%) through conventional 
Echo.14 patients (28%) have diastolic dysfunction through TDI.
The group (18 patients) that was diagnosed as having diastolic dysfunction 
by conventional method differs from the group without diastolic dysfunction only on 
two aspects - IVRT and PVa velocity. But the group identified by TDI have clear cut 
differences in several parameters, like Em velocity, Am velocity, Em/Am ratio, 
IVRT, LA diameter and septal wall thickness. This shows the relative insensitivity 
of conventional Echo Doppler methods in diagnosing diastolic dysfunction.
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Table IV
Comparative study of diastolic dysfunction group 
and without diastolic dysfunction
Diastolic Disfunction
No Yes
Mean SD Mean SD
Student independent t-test
FBS 131.1
0
23.8
9
154.3
9
34.3
9
t=2.65 P=.01 significant
METS 12.39 2.10 10.52 2.82 t=1.19 P=0.003 significant
EF 68.22 7.51 64.21 5.65 t=2.37 P=0.002 significant
lv_mass 78.92 2.15 82.45 2.97 t=3.31 P=0.001 significant
LA-diameter 33.50 1.92 34.87 2.25 t=2.30 P=0.03 significant
Lv_dias_diameter 50.56 2.96 51.00 3.41 t=0.49 P=0.62 not significant
SEPTAL WALL 
THICKNESS
7.56 1.15 7.98 1.32 t=1.21 P=0.22 not significant
E_A_ratio 1.34 .21 1.28 .44 t=0.63 P=0.53 not significant
dt 163.6
7
38.7
4
211.2
9
61.5
4
t=3.07 P=0.003 significant
pva 27.40 5.11 31.91 7.34 t=2.19 P=0.03 significant
S_D_ratio 1.06 .18 .98 .48 t=0.65 P=0.52 not significant
Em 13.72 2.97 13.06 5.37 t=0.49 P=0.62 not significant
Am 9.72 2.49 11.25 2.74 t=2.08 P=0.04 significant
Em/Am 1.41 .32 1.19 .53 t=1.71 P=0.09 not significant
E/Em 8.22 1.96 7.12 2.52 t=0.83 P=0.41 not significant
Fasting blood sugar levels are significantly elevated in the group with 
diastolic dysfunction. But there is no significant variation between those with 
diastolic dysfunction by TDI or conventional methods.
Among 18 patients identified by Conventional Echo Doppler to have 
diastolic dysfunction, 3 patients had Grade II diastolic dysfunction. These 3 patients 
were identified both by TDI and conventional Echo Doppler. The E/A Ratio was > 
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1, DT > 200 MS and IVRT < 90 msec and PVA velocity > 35 cm/sec. PVa Velocity 
> 35 cm/sec confirms that the patients have only Grade II diastolic dysfunction.
All patients identified by TDI have Em/Am Ratio < 1 and Em velocity < 8.5 
cm/sec, clearly indicating diastolic dysfunction. These findings clearly show that 
tissue Doppler imaging is superior in the early diagnosis of diastolic dysfunction in 
diabetics. TDI is also more sensitive method.
10 patients have diastolic dysfunction both by conventional method and TDI. 
In these patients the EA ratio was < 1 in 7 patients and PVa velocity was > 35 
cm/sec in all the patients. TDI parameters of LV diastolic dysfunction (Em/Am ratio 
< 1 and Em velocity < 8.5 cm/sec) was present in all the patients. This again shows 
that TDI can pick up individuals with diastolic dysfunction from among individuals 
in whom the conventional parameters for the diagnosis of diastolic dysfunction was 
varying.
Comparison between diastolic dysfunction group and without diastolic 
dysfunction (Table III)
The fasting blood sugar is significantly elevated in the diastolic dysfunction 
group (t=2.65 P=0.01 significant).The diastolic dysfunction group shows a decline 
of about 15% exercise capacity. LV mass is significantly elevated in diastolic 
dysfunction group (t=3.31 P=001 Significant) Ejection fraction is significantly 
decreased in diastolic dysfunction group when compared to group without diastolic 
dysfunction. There is significant increase in the LA diameter in the diastolic 
dysfunction group (t=2.30 P=0.003 Significant).
Reduction in E/A Ratio is not significant.
Other diastolic function parameters like DT, PVa and Am are significantly 
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elevated in Diastolic dysfunction group. Other variable like Lv diastolic diameters, 
spetal wall thickness, S/D ratio Em/Am ratio do not show significant differences.
SARAIVA ET AL showed in their study that Tissue Doppler Imaging can 
identify asymptomatic diabetics with diastolic dysfunction. In their study both Echo 
Doppler and TDI were employed to evaluate diastolic dysfunction. Tissue Doppler 
imaging identified diastolic dysfunction in 26.6% of diabetics, while the classical 
criteria did so in 40.5% of the cases. The group identified by classical criteria did 
not differ significantly from patients without diastolic dysfunctions, while in the 
group identified by TDI significant differences were highlighted. These findings are 
nearly similar to our findings. Their study showed close correlation between these 
groups with regard to LV mass index whereas our study does not find any 
correlation in this aspect.
Savaiva Et al concluded in their study justifying the use of TDI for the 
assessment of diastolic dysfunction with otherwise healthy hearts(15).
Comparison between study group and controls (Table IV)
There are significant differences between these two groups. This is only as 
expected. The fasting blood sugar (FBS) is much elevated in the study group. There 
is a 21.4% reduction in exercise tolerance in diabetics compared to controls. The E/
A ratio is significantly decreased in the study group than the control group. There is 
26% increase of deceleration time in diabetic group when compared to controls. 
Pulmonary venous atrial reversal velocity is significantly increased in diabetics as a 
group. S/D ratio is significantly reduced. 16% increase in IVRT was noted in 
Diabetic group. Other diastolic functional parameters like Em, Am, Em/Am, E/Em 
ratios  show significant differences in these two groups.
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Table V
Echocardiographic characterstics of groups with diastolic dysfunction 
identified by conventional and TDI methods. 
con_tiss N Mean Std. Deviation Student independent t-test
FBS Conv 18 151.61 17.584 t=0.70 P=49 not significant
TDI 14 156.93 25.281
METS Conv 18 10.671 2.5341 t=1.35 P=0.03 significant
TDI 14 9.118 1.6718
EF Conv 18 65.44 6.271 t=0.32 P=0.75 not significant
TDI 14 66.14 5.749
lv_mass Conv 18 81.42 2.360 t=1.76 P=0.09 not significant
TDI 14 83.33 3.771
LA-diameter Conv 18 33.89 1.779 t=2.79 P=0.01 significant
TDI 14 35.71 1.899
Lv_dia_ diameter Conv 18 51.39 3.466 t=0.47 P=0.64 not significant
TDI 14 50.79 3.766
SEPTAL WALL 
THICKNESS
Conv 18 7.72 1.227 t=2.11 P=0.04 significant
TDI 14 8.64 1.216
E_A_ratio Conv 18 1.061 .4060 t=0.41 P=0.69 not significant
TDI 14 1.121 .4246
dt Conv 18 257.06 56.637 t=1.54 P=0.13 not significant
TDI 14 226.93 52.305
pva Conv 18 35.22 3.388 t=0.11 P=0.91 not significant
TDI 13 35.00 7.735
S_D_ratio Conv 18 1.02 .646 t=1.07 P=0.29 not significant
TDI 13 .80 .387
Em Conv 18 12.00 2.970 t=5.91 P=0.001 significant
TDI 14 7.14 .864
Am Conv 18 10.22 2.290 t=2.76 P=0.01 significant
TDI 14 12.50 2.345
Em/Am Conv 18 1.211 .4861 t=4.94 P=0.001 significant
TDI 14 .552 .1173
E/Em Conv 18 7.417 2.8932 t=1.54 P=0.13 not significant
TDI 14 8.779 1.8082
IVRT Conv 18 111.50 16.797 t=2.02 P=0.05 significant
TDI 14 99.24 17.323
Table V-A
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Group-Sex Cross Tabulation
Count
Sex
Male Female
Total
Group Study 34 16 50
Control 16 4 20
Total 50 20 70
χ2 = 1.01 P=0.32 not significant
There were 34 males and 16 females in the study group and 16 males and 4 
females in the Control Group. The difference in the numbers between males is 
statistically not significant.
Table V-B
Sex*con-tdi
con_tdi
Conv TDI
Total
Sex F 8 3 11
M 10 11 21
Total 18 14 32
χ2 = 1.85 P=0.17 not significant
Among the females 8 were identified to have diastolic dysfunction by 
conventional method and 3 patients by TDI. But 10 males were identified to have 
diastolic dysfunction by conventional method and 11 males by TDI method. 
However this difference is not statistically significant.
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Table VI
Comparison between Echocardiac characteristics of study group and controls
Group
Study Control
Mean SD Mean SD
Student independent t-test
FBS 154.1
0
22 94.55 13 t=11.3 P=0.001 significant
METS 10.90 2.5 13.87 1.8 t=4.85 P=0.001 significant 
EF 66.64 7 61.75 4 t=3.07 P=0.003 significant
lv_mass 891.0
5
3 80.16 2 t=1.13 P=0.26 not significant
LA-diameter 34.26 2 35.15 3 t=1.51 P=0.13 not significant
Lv_dias_diameter 50.92 3 50.80 3 t=0.13 P=0.89 not significant
SEPTAL WALL 
THICKNESS
7.92 1 7.75 1 t=0.49 P=0.62 not significant
E_A_ratio 1.18 .4 1.58 .3 t=4.33 P=0.001 significant 
dt 215.0
0
63 159.1
5
20 t=3.85 P=0.001 significant
pva 32.61 6 24.23 5 t=4.29 P=0.001 significant
S_D_ratio .97 0 1.10 0 t=0.98 P=0.001 significant
Em 11.26 4 18.15 4 t=6.97 P=0.001 significant
Am 10.68 3 11.30 3 t=0.85 P=0.001 significant
Em/Am 1.10 .5 1.60 .2 t=4.38 P=0.001 significant
E/Em 8.09 2.3 5.69 1.7 t=4.14 P=0.001 significant
INRT 101.4
5
20 83.60 8 t=3.70 P=0.001 significant
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Although there is increase in LV mass, LV diastolic diameter and septal wall 
thickness in the study group as a whole, it is not statistically significant. This is 
important because there is significant increase in these variables in the diastolic 
dysfunction group and this indicates the increase in LV mass index is mainly seen in 
those with diastolic dysfunction.
Table VII-A
Group
Study Control
Mean SD Mean SD
Student independent t-test
Age 46.70 7 43.75 7.1 t=1.58 P=0.001 not significant
bmi 25.53 4.9 24.10 1.9 t=1.25 P=0.001 not significant 
Comparison of body mass index among male and females is not statistically 
significant both among study group and control group.
Body mass Index variation in patients with conventional and TDI group is 
not statistically significant.
Table VII-B
con_tiss N Mean Std. Deviation Student independent t-test
bmi Conv 18 26.644 2.7509 t=0.70 P=91 not significant
TDI 14 24.743 1.9559
DISCUSSION
The study group consists of 50 patients. None of them have systolic 
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dysfunction. 18 patients were identified by to have diastolic dysfunction by 
conventional echo Doppler method and 14 by TDI method. But in the group 
identified by conventional Echo Doppler method, not all parameters were full filled. 
The E/A ratio is normal in most of the patients. But these patients were identified to 
have diastolic dysfunction on the basis of prolonged IVRT and PVa velocity. But in 
TDI group, all 14 patients fulfilled both criteria for diagnosis (E'/A' ratio less than 1 
and E' velocity less than 8.5 cm/sec). More over the group identified by 
conventional Echo Doppler method differs very little from those patients without 
diastolic dysfunction. The exercise capacity of the patients identified by TDI shows 
a reduction of 17% when compared to those without diastolic dysfunction.
Together with diastolic dysfunction and absence of systolic dysfunction, 
these are required items by the guidelines of the European study group on diastolic 
heart failure for the formulation of diastolic heart failure. There were 36% 
prevalence of diastolic dysfunction in our study according to the above mentioned 
guide lines. The majority of patients were by IVRT and PVA velocity. Whereas 
there are a number of guidelines for the diagnosis of Diastolic dysfunction, the 
reliability of diagnosing diastolic dysfunction on the be basis of only 2 parameters 
(IVRT & PVA) is in doubt, on the other hand, the group identified by TDI has bold 
differences from the no-diastolic dysfunction group like decreased Em/Am ratio, 
prolonged IVRT, decreased Em and increased LA diameter.
Other studies have reported diastolic dysfunction prevalence in diabetes 
according to tissue Doppler imaging criteria.
VINEREANU ET AL studied patients with Type II DM, recorded the Em velocity at the 
lateral mitral annulus level. They described that 29% of the patients presented a lateral Em velocity 
inferior to 8 cm/sec. However they included patients with hypertension. In our study patients with 
hypertension were excluded and 28% of patients had septal Em velocity less than 8.5 cm/sec. (34)
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Another study evaluated the septal annulus Em and Am myocardial 
velocities and found a prevalence of 78% of Em/Am ratio < 1 in diabetics without 
left ventricular hypertrophy. High prevalence of hypertension among diabetics 
together with higher age of the sample may be responsible for such high figures and 
as such cannot be compared with our study. We have excluded hypertension and 
patients with age > 55 years.
Boyer JK et al demonstrated in type II DM nor motensive patients a 
prevalence of 75% diastolic dysfunction, using as diagnostic criteria the presence of 
both septal and lateral Em velocity less than 8 cm/sec.(36)
Our study showed a reduced exercise capacity in diabetic subjects with 
diastolic dysfunction. The reduction is 15%. There is positive correlation between 
METS and E/A ratio. There is negative correlation between DT (declaration time) 
and METS. There is also positive correlation between Em/Am ratio. Such 
correlation has been reported by others also.
A modest correlation between septal myocardial velocity and exercise 
duration in diabetes has also been recently reported. Diabetics with diastolic 
dysfunction assessed by tissue Doppler imaging had both E/A and Em/Am ratios 
correlated inversely with age. Patients identified with diastolic dysfunction by TDI 
presented with high LV mass index and higher LA diameter and septal wall 
thickness. Significantly there is insignificant increase in LV diastolic dimensions.
There appears to be no correlation between metabolic control and diastolic 
dysfunction.
We have found out that there is a higher E/Em ratio in diabetics with 
diastolic dysfunction diagnosed by TDI. There is a negative correlation between Em 
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septal myocardial velocity and LA dia-meter. These findings signal to the presence 
of higher LV filling pressures in diabetics with diastolic dysfunction.
Diabetic myocardial changes may be due to metabolic derangements, 
microvascular disease and myocardial fibrosis. The most prominent histopathologic 
changes in diabetic patients without CAD and hypertension are myocellular 
hypertrophy and myocardial fibrosis. As hypertension and LVH frequently co exist 
with diabetes, we studied patients without hypertension and LVH.
Chronic abnormalities in myocardial carbohydrate and lipid metabolism due 
to insulin deficiency may result in reduced adenosine triposphatase activity, 
decreased ability of sarcoplasmic reticulum to take up calcium.
 Zhi You Fang et al demonstrated that peak strain rate were significantly 
reduced in patients with diabetes mellitus and that these changes were analogous to 
those associated with LVH.
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CONCLUSION
The following conclusions were derived from our study.
1. Diastolic dysfunction is present in asymptomatic diabetics.
2. Conventional Echo Doppler is a relatively insensitive method in the 
diagnosis of early diastolic dysfunction.
3. Tissue Doppler imaging can identify diastolic dysfunction more 
accurately than conventional Echo Doppler method.
4. The reduced exercise tolerance in diabetics with diastolic dysfunction 
recognized by tissue Doppler imaging suggests a potential clinical 
application for tissue Doppler imaging in the assessment of diastolic 
dysfunction in normotensive diabetics apparently free from heart disease.
5. In this study, we found out that tissue Doppler imaging is able to unmask 
the presence of diastolic dysfunction in asymptomatic type II diabetics 
under-scoring its relation to reduced exercise tolerance, a well recognized 
ominous prognostic marker. Conversely classical criteria based on PW 
Doppler do not seem to have the same ability.
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LIMITATIONS OF THE STUDY
All the patients are on oral hypoglycaemic agents. Average fasting blood 
sugarwas154mg%.It shows most of the patients have imperfect and unsuccessful 
control of blood sugar. A greater spectrum of control might have facilitated in 
establishing a relationship between myocardial dysfunction and glycaemic control.
Exclusion of an ischaemic contribution was mainly based on a normal 
resting ECG, normal TMT and absence of RWMA in 2D-echo. This does not 
exclude the possibility of CAD, because of the possibility of false negative results. 
But such false negative results are usually associated with mild disease and as such 
it seems unlikely that a major ischaemic contribution was present. This limitation is 
unavoidable because it would be difficult to justify coronary angiography in 
asymptomatic diabetic patients on ethical grounds.
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